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ABSTRACT 
In the context of drug discovery and development, much effort has been exerted to 
determine which conformers of a given molecule are responsible for the observed biological 
activity. In this work we aimed to predict bioactive conformers using a variant of supervised 
learning, named multiple-instance learning. A single molecule, treated as a bag of conformers, is 
biologically active if and only if at least one of its conformers, treated as an instance, is 
responsible for the observed bioactivity; and a molecule is inactive if none of its conformers is 
responsible for the observed bioactivity. The implementation requires instance-based embedding, 
and joint feature selection and classification. The goal of the present project is to implement 
multiple-instance learning in drug activity prediction, and subsequently to identify the bioactive 
conformers for each molecule.  
We encoded the 3-dimensional structures using pharmacophore fingerprints which are 
binary strings, and accomplished instance-based embedding using calculated dissimilarity 
distances. Four dissimilarity measures were employed and their performances were compared. 1-
norm SVM was used for joint feature selection and classification. The approach was applied to 
four data sets, and the best proposed model for each data set was determined by using the 
dissimilarity measure yielding the smallest number of selected features.  
The predictive abilities of the proposed approach were compared with three classical 
predictive models without instance-based embedding. The proposed approach produced the best 
predictive models for one data set and second best predictive models for the rest of the data sets, 
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based on the external validations. To validate the ability of the proposed approach to find 
bioactive conformers, 12 small molecules with co-crystallized structures were seeded in one data 
set. 10 out of 12 co-crystallized structures were indeed identified as significant conformers using 
the proposed approach. 
The proposed approach was demonstrated to be highly competitive with classical 
predictive models, hence it is very powerful for drug activity prediction. The approach was also 
validated as a useful method for pursuit of bioactive conformers. 
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BACKGROUND  
In the context of drug discovery research, it is challenging but of great importance to be 
able to determine which 3-dimensional (3D) shapes (so-called conformers) of a given molecule 
are responsible for its observed biological activity. Due to structural flexibility, a molecule may 
adopt a wide range of conformers and the identification of the bioactive conformers is extremely 
important in order to understand the recognition mechanism between small molecules and 
proteins, which is crucial in drug discovery and development. Until now, the most reliable 
approach to obtain the bioactive conformer is to use the X-ray crystal structure of a ligand-
protein complex; however, the number of such structures is limited because of the experimental 
difficulty in obtaining the crystals, especially for transmembrane proteins, such as G protein-
coupled receptors (GPCR) [1, 2] and membrane transporters. We were interested to apply to this 
problem a machine-learning approach which does not require crystal structures, named multiple-
instance learning (MIL) via embedded instance selection (MILES). MILES has been 
demonstrated as an efficient and accurate approach to solve different multiple-instance problems 
[3], in particular, to predict drug activity using Musk data sets. In the context of drug activity 
prediction, MILES enables the construction of a quantitative structure-activity relationship 
(QSAR) model, and subsequently the identification of bioactive conformers. 
MIL is a variant of supervised learning, and it has been applied for a variety of learning 
problems including drug activity prediction [4], image database retrieval [5], text categorization 
2 
 
[6], and natural scene classification [7]. In the context of drug activity prediction, the observed 
biological activity is associated with a single molecule (bag) without knowing which conformer 
or conformers (instances) are responsible. Furthermore, a molecule is biologically active if and 
only if at least one of its conformers is responsible for the observed bioactivity; and the molecule 
is inactive if none of its conformers is responsible (Figure 1). A difficulty in implementation 
arises from the fact that different molecules have a different number of conformers, since some 
molecules having multiple rotatable bonds are highly flexible and others with rigid structures 
only have a small numbers of conformers (Figure 2). 
 
Figure 1. Cartoon representation of the relationsip between molecules and conformers. 
Mi, i=1, 2, 3, 4 represent the molecules (bags), circled by dashed lines. The solid triangles in M1, 
circles in M2, squares in M3, and stars in M4 represent conformers for different molecules. 
Molecules 2, 3, and 4 were biologically active since they had at least one bioactive conformer, 
whereas molecule 1 was inactive since none of its conformers was bioactive. The distance 
between two molecules, M1 and M3, was calculated by the minimum distance D(M1, M3). 
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Figure 2. Three molecules with various numbers of conformers. 
Since losartan has multiple rotatable bonds represented by various dihedral angles, Φk, k = 
1,2,3,4,5, it adopts a large number of conformers and only one of them is responsible for the 
bioactivity, which is called bioactive conformer. However, the other two molecules, paullone and 
indirubin, can only adopt single conformer which is the bioactive one. 
The overall strategy for structural and data mining using MILES (Figure 3) is 
summarized here. First of all, a complete sampling of conformational space provides a large 
number of conformers for each molecule. The molecules are themselves each already labelled as 
either positive or negative. However, the labels for the conformers are unavailable during the 
model generation. Each conformer is denoted by a unique pharmacophore fingerprint which is a 
superior feature-based 3D descriptor unveiling structural similarity and diversity [8-11]. The 
pharmacophore fingerprint is encoded into a binary string which indicates the presence or 
absence of a match to individual pharmacophore models. Since the exhaustively enumerated 
fingerprints have millions of bits, which may be beyond computational limits, a significance 
analysis of pharmacophore models [12] is employed to determine the optimal subset of bits of 
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the fingerprint. Subsequently, MILES converts the MIL to a standard supervised learning 
problem by embedding bags (molecules) into an instance-based (conformer-based) feature space 
via structural dissimilarity measures [13]. Finally, 1-norm SVM is applied to select the most 
important features, identifying the highly significant conformers which help the most to 
distinguish active and inactive molecules, and, simultaneously, to construct a predictive 
classification model.  
 
Figure 3. Overview of the MILES approach. 
(1) Structure preprocessing and conformational sampling. (2) Creating pharmacophore 
fingerprints and significance analysis of pharmacophore models. (3) Instance-based feature 
mapping based on structural similarity measures. (4) Joint feature selection and classification 
using 1-norm SVM. 
In the present work, MILES has been applied to study the biological activities of several 
sets of molecules interacting with different receptor targets including glycogen synthase kinase-3 
(GSK-3), cannabinoid receptors (CBrs), and P-glycoprotein (P-gp). All of these receptors have 
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been emerging as increasingly important therapeutic targets. GSK-3 is a multifunctional 
serine/threonine protein kinase involved in the regulation of a wide range of cellular functions, 
including glucose metabolism, neuronal processes, chronic inflammation, cell proliferation and 
apoptosis [14]. CBrs are a class of GPCRs and have been targeted for various disease conditions 
such as obesity, drug abuse disorders, inflammatory diseases, anorexia and vomiting [15]. P-gp, 
a membrane transporter, is responsible for drug efflux and multidrug resistance, especially to 
cancer drugs [16]. Except for GSK-3, the other proteins are membrane-associated and there is no 
available crystal structure for them. The identification of bioactive conformers for the molecules 
targeting membrane-associated proteins using MILES could be highly informative and desirable. 
Identified conformers can be used in various drug discovery approaches such as scaffold 
hopping, target fishing, and 3D structural alignment for 3D quantitative structure-activity 
relationship (QSAR) studies. 
Based on our calculations, MILES is highly competitive with the classical QSAR 
approaches which do not include instance-based feature mapping in terms of predictive abilities.  
Meanwhile, we have validated that MILES has the ability to identify a subset of highly relevant 
conformers, including the bioactive conformers, which contribute to the classification of active 
and inactive molecules.  
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METHODOLOGY 
Data Set Preparation 
Four different data sets were compiled through extensive literature search. Data set I 
includes all molecules exhibiting inhibitory activities for human GSK-3. Data sets II and III 
contain molecules modulating the intracellular activities of human CBrs. Since there are two 
identified CBr subtypes, CB1 and CB2, two different data sets were prepared to study the 
protein-small molecule interactions of the receptors separately. Some of the molecules which 
have reported binding affinities for both CB subtypes were included in both data sets II and III. 
Data set IV contained compounds which had been tested as substrates of P-gp.  
The molecules collected for each data set were labelled as either positive or negative. A 
positive molecule has a high binding affinity with the target protein, whereas a negative 
molecule has a low binding affinity. A single cutoff value has been widely used in the 
development of classification models. However, it is inaccurate to use a single cutoff value for 
the separation of continuous biological activities in the context of drug activity prediction. The 
biological activities are represented by continuous numbers, and the small differences between 
the values above and below the cutoff value cannot imply the distinct nature of binding affinity. 
Furthermore, the small difference in the bioassay results may arise from systematic errors 
introduced by different experimental protocols used in different labs, so it cannot be used as solid 
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evidence for the classification of molecules. Therefore, multiple cutoff values were employed to 
separate molecules into positive and negative classes. 
For data set I, the molecules were categorized into positive and negative molecules using 
cutoff values of IC50 ≤ 50 nM and IC50 ≥ 500 nM, respectively. The molecules having inhibitory 
activities between the two cutoff values were considered as moderately active molecules, and 
were discarded from the data set. The wide margin between the two cutoff values was used to 
account for the variances in biological assays. For data set II and III, the molecules were 
classified as positive if the Ki ≤ 50 nM or IC50 ≤ 100 nM or EC50 ≤ 100 nM (IC50 is 
approximately twice as large as Ki based on the definition); and the molecules were classified as 
negative if the Ki ≥ 500 nM or IC50 ≥ 1000 nM or EC50 ≥ 1000 nM. The labels for the molecules 
in data set IV indicated whether or not the molecule is a substrate for the target protein. They 
were obtained from the literature [12]. 
Division of Training and Test Set   
External validation was achieved using an independent test set. The split of the data set 
into training and test sets was carried out using Kohonen self-organizing maps (SOM) in Canvas 
1.4 from Schrödinger Suite 2011. The SOM is trained using unsupervised learning to produce a 
square 2D grid map from the high dimensional input space. Each grid cell (neuron) contains a 
cluster of structurally similar molecules defined by the input vectors. The SOM takes advantage 
of clustering capabilities so that the selected training set can represent the independent test set in 
terms of the input space and chemical domains. Molecular pharmacophore fingerprints were 
used to describe the relevant structural information of the molecules and were used as input 
variables to build the SOM. The grid size of the map depends on the number of molecules in the 
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data set. For data sets I, II, and III, the Kohonen maps built included 10 10 neurons and 500 
epochs. For the data set IV, a Kohonen map consisting of 8 8 neurons and 500 epochs was built. 
The molecules were then stratified and sampled from each neuron to select the training and test 
set molecules. 
Preprocessing and Conformational Sampling  
The molecules (bags) can be represented by Mi, i=1,···,l where l is the total number of 
molecules. The 3D molecular structures were generated using the Ligprep module from 
Schrödinger Suite 2011, and then subjected to preprocessing to enumerate all the possible 
tautomers. The protonation states of ionizable groups were set to match pH = 7.4, and the 
stereochemistry was retained from the original 3D structures. In order to explore the 
conformational space exhaustively, the mixed torsional/low mode sampling method was 
employed, using MacroModel from Schrödinger Suite 2011. The torsional sampling involves 
multiple Monte Carlo minimum searches for global exploration, and the low mode 
conformational search allows for automatic local exploration. The torsional increment for each 
rotatable bond was set to 15° and the maximum number of total steps for torsional sampling was 
1,000. The energy window for saving structures was set to 83.7 kJ/mol (20 kcal/mol). The small 
torsional increment and wide energy window were employed to provide a reasonable coverage of 
the conformational space. Each enumerated conformer was energy minimized to eliminate 
unreasonable geometries and reduce internal steric clashes, using the Polak-Ribière conjugate 
gradient method with a gradient convergence threshold of 0.05 and a maximum of 500 iterations. 
To remove redundant conformations, the maximum atom deviation cutoff was set to 1.5 Å. As a 
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result, each molecule Mi has several possible conformers Cij, j=1,···,ni, where ni is the number of 
conformers (instances) for molecule i.  
In order to validate that MILES can identify the bioactive conformers, we seeded 12 co-
crystallized conformers, one for each of 12 molecules, in the set of sampled conformers for data 
set I. The validation process will be described in the following sections. 
Generation of Pharmacophore Fingerprints 
The pharmacophore fingerprint as a measure of molecular similarity and diversity based 
on 3D pharmacophoric shape was enumerated using Canvas 1.4 from Schrödinger Suite 2011. 
Each pharmacophore fingerprint associated with a unique conformer can be represented by a 
binary string, such as Pij = {p1,···,pk, ···,pm} and encodes quantitative structural information for 
conformer Cij, where each bit value pk, k=1,···,m indicates the presence or absence of a match to 
a single pharmacophore model, representing a unique 3D arrangement of a number of 
pharmacophore features. If the conformer fits the pharmacophore model for a particular k, in 
other words if the functional groups of the conformer fully overlap on all the pharmacophore 
features in the model, pk equals 1; otherwise, pk equals 0. As a result, each conformer is 
associated with a unique pharmacophore fingerprint as a conformational signature, which 
enables us to describe quantitatively the 3D structural information (Figure 4). The 
pharmacophore features employed in the models consist of hydrogen bond donor (D), hydrogen 
bond acceptor (A), hydrophobic group (H), negatively charged group (N), positively charged 
group (P), and aromatic ring (A). In the present study, only four-feature based models were 
employed in order to allow a reasonable description of 3D orientation of the structures and retain 
information about molecular chirality, which is lost in three-feature based models. Different 
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combinations of four out of six pharmacophore features were exhaustively enumerated and inter-
feature distances were varied from 2.0 Å to 20.0 Å to form the different pharmacophore models. 
Each pharmacophore feature was treated as a bin with width 2.0 Å, and the bin overlap threshold 
was 1.0 Å. To fit to a model the conformer must fit to each of the four features in the model. The 
maximum distance between pharmacophore features was set to 20.0 Å in order to be able to 
cover the largest molecular structures in the databases. To obtain a unique pharmacophore 
fingerprint for single molecule, binary union operation was applied on a bag of pharmacophore 
fingerprints for the conformers adopted by that molecule (Figure 5). The originally enumerated 
fingerprints were subject to occurrence-based filtering to remove the pharmacophore models 
present in less than 5% of the total number of molecules, since the pharmacophore models with a 
very low occurrence are not useful for discriminating between positive and negative classes. 
 
Figure 4. Pharmacophore fingerprint for single conformer. 
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Figure 5. Pharmacophore fingerprint for single molecule. 
Significance Analysis of Pharmacophore Models 
The post-filtered pharmacophore fingerprints still have too many bits that lack 
information content, as indicated by too many „0‟ values. Therefore a nonparametric supervised 
learning approach, motivated by the significance analysis of microarrays (SAM) algorithm 
proposed by Tibshirani et al. [17], was applied to elucidate a consistent pattern from the 
numerous bits of pharmacophore fingerprints. The detailed implementation and customization of 
the relevant procedures has been described in [12]. The ranking score for each pharmacophore 
model was computed based on a two-class t-statistic, which calculates the ratio of the difference 
of occurrences of that model in positive and negative classes and compares to the standard 
deviation of occurrence measures. Pharmacophore models with ranking scores greater than a 
threshold have statistical significance, where the threshold was computed at the 90th percentile 
among 500 random permutations of the class labels across all the molecules. In order to 
distinguish truly significant and falsely significant pharmacophore models, that ranking score 
serving as a true score was then compared with a reference score computed from the same set of 
random permutations. If the difference between the true score and the reference score exceeds a 
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cutoff threshold (called Δ) then the pharmacophore model is truly significant; otherwise it is 
falsely significant. .  
Instance-based Feature Mapping 
MILES provides a framework to convert a MIL problem to a standard supervised 
learning problem via instance-based embedding. All the conformers (instances) belong to the 
instance-based feature space. For convenience, all conformers in all molecules were lined up 
together, and were re-indexed in the embedded feature space as C
r
, r=1,···,n where      
 
   . 
Instance-based feature mapping can be accomplished using calculated structural dissimilarities. 
Different binary string distance measures were tested, including the Soergel distance, Dice 
distance, Manhattan distance, and Rogers-Tanimoto distance (Table 1). The range of each 
dissimilarity measure was normalized to be [0, 1] by definition. Given a conformer Cij denoted 
by a binary string Pij, the dissimilarity measure, denoted as D(Cij, C
r
), is calculated based on the 
number of occurrences of bit matches. Since one molecule is defined as a bag of multiple 
conformers (instances), the dissimilarity measure for a molecule, denoted as D(Mi, C
r
), is 
calculated based on the minimum distance using the closest instance in the bag for Mi: 
      
      
 
       
   (1) 
The minimum distance calculation (Figure 1) extends the idea of the diverse density framework 
proposed for instance-based learning [18]. 
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Table 1. Metrics used for dissimilarity measurements. 
Dissimilarity Measure Definition
a
 
Soergel 
   
     
 
Dice 
   
      
 
Manhattan 
   
       
 
Rogers-Tanimoto 
       
           
 
a
 Let P1 and P2 be two pharmacophore fingerprints, a be the count of bits which are set to 1 in 
both P1 and P2, b be the count of bits which are set to 1 in P1 but not in P2, c be the count of bits 
which are set to 1 in P2 but not in P1, and d be the count of bits which are set to 0 in both P1 and 
P2. So a is called the number of total matches, b and c are called the number of single matches, 
and d is called the number of no matches. 
 
Joint Feature Selection and Classification 
Since the molecules in the training sets are highly flexible, instance-based embedding, 
which provides a framework to convert a MIL problem to a traditional supervised learning 
problem, may produce a very high dimensional feature space. But many features are redundant 
or irrelevant, and do not play an important role in the classification of molecules as positive or 
negative. So an efficient feature selection model is required for selection of an optimal subset of 
instance-based features. Considering its excellent performance in many applications [19], the 1-
norm SVM method was chosen as a joint approach to construct classifiers and to select important 
features simultaneously. The prediction model can be formulated as a linear classifier, 
              (2) 
where   denotes the class label as either positive or negative;   and   are model parameters 
which are optimized during model generation; and m corresponds to a molecule (bag), which is 
defined by an n-dimensional vector of dissimilarities calculated using (1), i.e., dissimilarities 
14 
 
with respect to all conformers in all molecules. The domain to (2) is therefore the space of R
n
, 
where n is the sum of all conformers in all molecules. The SVM approach constructs classifiers 
based on hyperplanes by minimizing a regularized training error, ξtraining (hinge loss), 
λP[•] + ξtraining (3) 
where P[•] is a regularizer, and λ is the regularization parameter, the only tuning parameter to be 
optimized by the user. In 1-norm SVM, the regularizer is chosen to be the 1-norm of the weight 
vector, 
           . (4) 
1-norm regularization favors sparse solutions, i.e., it drives many components of   to zero.  
Once the optimal solution, with values    and   , is obtained, the magnitude of its 
component   
  indicates the significance of the r-th feature (conformer) in the instance-based 
feature space. The features corresponding to non-zero entries in    are selected as important 
features, whose indices are specified as a set          
     ). They are needed for the 
classification problem of interest  
          
       
       
  . (5) 
Note that (2) is equivalent to (5) where all weights with 0 values are ignored. The domain of (5) 
is R
|Γ|
, a subspace of R
n
, defined by conformers whose weights are nonzero. The features 
selected as important are called prototype conformers. The plus or minus sign of   
  indicates the 
positive or negative contribution, respectively, of the r-th prototype conformer to the putative 
bioactive conformers for each individual molecule. 
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Our formulation of MILES works directly on a dissimilarity mapping, which is different from a 
similarity mapping described by Chen, et al. [3]. One can transform a dissimilarity mapping to a 
similarity mapping via an exponential function. However, this would introduce an additional 
super parameter, σ. Although, a proper choice of σ could improve the performance of a model, 
the selection of a proper value for σ increases the computational cost significantly. Hence we use 
a dissimilarity mapping to reduce the computational cost. 
Identification of Bioactive Conformers 
One appealing advantage of the MILES algorithm is that it can identify the most 
significant instances in a bag according to their contributions to the classification of that bag. In 
the context of drug activity prediction, we can identify the most significant conformers, called 
the bioactive conformers, for each molecule. The putative bioactive conformers are the 
conformers that contributed the most to the classification of positive and negative molecules. 
 
Figure 6. Identification of bioactive conformers. 
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Molecule i was circled by a dashed line and its conformers were represented by solid triangles. 
The plus circles represent the positively contributing prototype conformers and the minus circles 
represent the negatively contributing prototype conformers. The identification of bioactive 
conformers was accomplished by calculating the total contributions from the closest prototype 
conformers. 
The identification of bioactive conformers can be accomplished with the assistance of the 
prototype conformers mentioned above (Figure 6). Given a molecule Mi with its conformers Cij, 
j=1,···,ni, we define an index set                          
        ), which includes the 
index for conformers closest to each prototype conformer. Hence,   defines a minimal set of 
conformers, called significant conformers, which are responsible for the classification of Mi. By 
definition, each prototype conformer in set   has a single conformer in set   closest to it, but 
each significant conformer in set   may have multiple prototype conformers in set   closest to it. 
So we need to define an index set for each significant conformer in set   that includes the index 
for the prototype conformers closest to it, which is given as 
             
                
    ). As a result, the contribution of each significant 
conformer to the classification of molecule can be calculated as 
           
         
  
     
 (6) 
where         denotes the contribution of the conformer      to the classification of the molecule 
Mi. The conformer in set   making the highest contribution is selected as a bioactive conformer.  
In order to validate the ability of MILES to identify the bioactive conformers, the 
contributions         for the 12 seeded conformers, which were taken directly from co-
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crystallized complex structures, were calculated and ranked among all the conformers sampled 
for those 12 molecules.  
Classical QSAR Methods without Instance-based Embedding 
In order to examine the predictive performance of MILES, conventional classification 
approaches based on classical QSAR principles without instance-based embedding were tested 
for comparison. Since one molecule is defined as a bag of multiple conformers (instances), the 
pharmacophore fingerprint associated with a single molecule was obtained from the binary union 
of all of the pharmacophore fingerprints associated with the conformers of that molecule. The 
same occurrence-based filtering and significance analysis of pharmacophore fingerprints were 
performed to select the optimal subsets of the fingerprints which constituted the feature space for 
the classical QSAR studies. Three widely used classification algorithms including decision tree 
(DT) [20], 1-norm SVM [19], and random forest [21] were employed for comparison with 
MILES-SVM. The decision tree is a greedy method based on a recursive partitioning algorithm. 
The classification trees were constructed using the „classregtree‟ function implemented in Matlab 
R2011b. The tree-based classification method can account well for multiple binding mechanisms 
[12]. Gini‟s diversity index was used for recursive partitioning, and the minimal number of 
molecules per tree leaf was set as 3 to terminate tree growing. The 1-norm SVM model is a 
statistical learning theory derived from the structural risk minimization principle and Vapnik-
Chervonenkis (VC) dimension [22]. It is different from the tree-based method and served as an 
alternative comparison. Since the major drawback of DT is its low prediction caused by the 
overfitted tree-based structure, the ensemble learning method, random forests [21], can deliver 
improved prediction while retaining the appealing properties of tree-based methods. It is a 
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collection of decision trees which are grown from bootstrapping samples of the original data 
without tree pruning, and has been demonstrated as one of the most powerful tools available for 
data exploration [23]. The Matlab implementation (randomforest-matlab v0.02) was used with 
default parameters. 
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RESULTS AND DISCUSSION 
Data Set Preparation and Division 
According to the criteria used to label positive and negative molecules, the number of 
molecules in each of two classes was balanced for four data sets. Data set I has 266 molecules as 
positive and 258 molecules as negative; data set II has 253 molecules as positive and 284 
molecules as negative; data set III has 307 molecules as positive and 188 molecules as negative; 
and data set IV has 122 molecules as positive and 128 molecules as negative. In terms of 
division of training and test sets, a stratified sampling was used to partition all four data sets into 
training and test sets at ratios around 3:1, respectively (Table 2).  
Table 2. Data set statistics. 
Data 
set 
No. of molecules in training set No. of molecules in test set Total no. of 
molecules Positive Negative Positive Negative 
I 199 188 67 70 524 
II 191 210 62 74 537 
III 247 131 60 57 495 
IV 94 93 28 35 250 
 
Conformational Sampling  
The molecules in different data sets had various conformational flexibilities, so the 
average number of conformers for each molecule was distinct for the four data sets (Table 3). 
The average number of conformers for each molecule was 43 in data set I, 89 in data set II, 86 in 
data set III, and 211 in data set IV. So the molecules in data set IV had the highest 
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conformational flexibility. The feature space constructed through instance-based embedding only 
consisted of the instances from training bags, in other words, the conformers from the molecules 
in the training set. The molecules in the test set were not used in the construction of the instance-
based feature space. So ntraining in Table 3 indicates the number of instance-based features used 
for embedding.  
Table 3. Conformational sampling and pharmacophore fingerprints. 
Data 
set 
ntraining
a
 ntest
b
 mpre-filtering
c
 mpost-filtering
d
 msignificant
e
 Δ*f 
I 17249 5399 1872521 243721 2979 1.77 
II 35434 12333 1670985 155220 14002 5.40 
III 32528 9942 1636254 145996 1542 1.80 
IV 41960 10746 13687602 161018 3467 1.66 
a
 The number of conformers in the training set; 
b
 the number of conformers in the test set; 
c
 the 
number of pharmacophore bits in the fingerprint originally enumerated; 
d
 the number of 
pharmacophore bits in the fingerprint after filtering; 
e
 the number of bits in the optimal subset of 
the pharmacophore fingerprint; 
f
 the optimal threshold value to select truly significant 
pharmacophore bits. 
Significance Analysis of Pharmacophore models 
Millions of pharmacophore models were originally enumerated for each data set, and the 
largest number of pharmacophore models was generated for data set IV. This correlated with the 
observation that the molecules in data set IV have the highest conformational flexibility. After 
occurrence-based filtering, only a small portion of the pharmacophore models was retained for 
each data set. For instance, 13% was retained for data set I, 9% for both data sets II and III, and 
1% for data set IV (Table 3).  
Significance analysis was subsequently performed upon those retained pharmacophore 
models. The threshold values were set to 100 equally spaced intervals from 0 to the largest 
difference between the ranking scores and reference scores. As the threshold value increases in a 
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bottom-up manner, the number of falsely significant pharmacophore models decreases, and the 
number of truly significant models remains roughly constant. So the optimal threshold values 
(Δ*) for each data set can be obtained when the number of falsely significant pharmacophore 
models drops to zero (Table 3). Subsequently, the optimal subsets of the pharmacophore 
fingerprint bits were obtained for four data sets (Table 3). Only a very small portion of the 
fingerprint bits were significant for classification, namely 1% in data set I, 9% in data set II, 1% 
in data set III, and 2% in data set IV.  
In the context of MIL, the optimal subsets of the binary strings were used to calculate the 
dissimilarity between two conformers for instance-based feature mapping. For the classical 
QSAR methods, the optimal subsets of the fingerprints were used as the 3D descriptors in the 
pharmacophore-based feature space for building classification models.   
Predictive Performance of MILES and Classical QSAR methods 
In the MILES model, the only tuning parameter λ was determined by a grid search. Five 
replications of 5-fold cross-validation were performed to assess the classification accuracies at 
each point over a fixed grid which ranged from 2
-8
 to 2
5
 with exponential increment in base 2. 
The median values for the 5 replications were used to find the optimal tuning parameters. During 
the cross-validation, the instance-based feature space was dynamically defined, which means that 
the conformers from the molecules in the internal test set, after random split of the training set, 
were excluded from the feature space. As a result, the optimal tuning parameters as well as the 
number of prototype conformers were obtained for four dissimilarity measures (Table 4).  
  
22 
 
Table 4. Optimization of tuning parameter λ for MILES. 
Data set Dissimilarity measure Cross-validation
a
 λ nb 
I 
Soergel 0.777 8.000 196 
Dice 0.761 4.400 165 
Manhattan
c
 0.803 4.400 130 
Rogers-Tanimoto 0.801 4.000 153 
II 
Soergel 0.865 0.001 103 
Dice 0.865 0.001 85 
Manhattan
c
 0.877 0.022 63 
Rogers-Tanimoto 0.868 0.069 72 
III 
Soergel 0.899 0.001 94 
Dice 0.901 0.001 75 
Manhattan 0.934 0.550 63 
Rogers-Tanimoto
c
 0.935 4.400 46 
IV 
Soergel 0.579 0.003 125 
Dice 0.544 0.031 111 
Manhattan 0.690 0.550 87 
Rogers-Tanimoto
c
 0.689 6.800 78 
a
 The median classification accuracy for 5 replications of 5-fold cross-validation; 
b
 the number of 
prototype conformers selected in the set  ; c The model selected based on the number of 
prototype conformers. 
 
Based on the internal validation, the classification accuracies were similar within each 
data set using four different dissimilarity measures. However, the numbers of prototype 
conformers selected were much different. For instance, in data set I and II, Manhattan distance 
yielded the smallest subset of selected prototype conformers, but in data set III and IV, Rogers-
Tanimoto yielded the smallest subset. Furthermore, Soergel distance yielded the largest subset 
for all the four data sets. The dissimilarity measure which yielded the smallest number of 
selected prototype conformers was chosen as the best MILES model and used later for 
comparison with classical QSAR models without instance-based embedding. 
After finding the optimal λ, a MILES model was identified from the training set and 
applied to the test set. In addition to comparing classification accuracy, denoted as the proportion 
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of correct predictions, Matthews Correlation Coefficient (MCC) [24] was also employed as a 
complementary indicator for the predictive performance. MCC is defined as:  
    
           
                             
 (7) 
where TP is true positive, TN is true negative, FP is false positive, and FN is false negative. 
MCC not only takes into account true positives and true negatives as classification accuracy 
does, but also false positives and false negatives. Thus it is considered as a balanced measure of 
the performance of binary classification (Table 5).  
Table 5. Predictive performance for different dissimilarity measures. 
Data set Dissimilarity measure 
Training set Test set 
Accuracy MCC Accuracy MCC 
I 
Soergel 0.972 0.944 0.854 0.714 
Dice 0.979 0.959 0.825 0.653 
Manhattan
a
 0.941 0.881 0.861 0.725 
Rogers-Tanimoto 0.961 0.923 0.861 0.725 
II 
Soergel 0.965 0.933 0.860 0.725 
Dice 0.965 0.933 0.868 0.745 
Manhattan
a
 0.978 0.956 0.904 0.807 
Rogers-Tanimoto 0.973 0.946 0.897 0.793 
III 
Soergel 0.989 0.977 0.846 0.706 
Dice 0.989 0.977 0.855 0.717 
Manhattan 0.979 0.954 0.838 0.686 
Rogers-Tanimoto
a
 0.947 0.885 0.846 0.711 
IV 
Soergel 0.904 0.823 0.667 0.301 
Dice 0.904 0.823 0.635 0.307 
Manhattan 0.957 0.918 0.714 0.433 
Rogers-Tanimoto
a
 0.898 0.811 0.794 0.584 
a
 The model selected based on the number of prototype conformers.  
 
In accordance to classification accuracy and MCC, the performance of different 
dissimilarity measures was dataset-specific. For data set I, both the Manhattan and Rogers-
Tanimoto distances were top-ranked and performed equally well on the test set, whereas on the 
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training set, the Soergel and Dice distances performed much better than the Rogers-Tanimoto 
and Manhattan distances, and the Rogers-Tanimoto distance performed slightly better than the 
Manhattan distance. In addition, the results did not change after removing the 12 seeded 
conformers which were used for the validation of identifying bioactive conformers. For data set 
II, the Manhattan distance was top-ranked on both training set and test set. For data set III, the 
Dice distance was top-ranked on both training and test sets. For data set IV, the Rogers-
Tanimoto distance performed much better on the test set, but on the training set it was not the 
top-ranked dissimilarity measure. It is interesting that for data sets I, II, and III the differences in 
the predictive performances of the four dissimilarity measures were very small, whereas for data 
set IV the differences were much larger. This may be caused by the high structural diversity in 
data set IV. The small difference in dissimilarity measures had a big impact on the predictive 
performance. The other interesting observation was that the classification accuracy and MCC 
provided the same indications for the predictive performance, which means that the data sets in 
the present work were highly balanced and good for benchmark studies.  
After comparing the predictive performance of different dissimilarity measures in the 
MILES model, the predictive performance of MILES models was compared with that of 
conventional classification approaches, which are based on classical QSAR principles without 
instance-based embedding. To find the optimal λ for 1-norm SVM on the basis of classical 
QSAR principles, the same procedure was employed, which resulted in the minimal subset of the 
most important pharmacophore models (Table 6).  
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Table 6. Optimization of tuning parameter λ for 1-norm SVM. 
Data set Cross-validation
a
 λ nb 
I 0.693 0.001 223 
II 0.880 2.000 80 
III 0.912 0.016 77 
IV 0.598 0.125 89 
a
 The median classification accuracy for 5 replications of 5-fold cross-validation; 
b
 the number of 
important pharmacophore bits. 
 
For data set I, the 1-norm SVM without instance-based embedding overfit the training 
set, producing perfect prediction on the training set and poor prediction on the test set. However, 
MILES performed fairly well on both the training and test sets without overfitting. MILES 
performed much better than decision trees and slightly worse than random forests in terms of the 
predictive power on the test set. For data set II, MILES was highly competitive with the other 
classical QSAR methods, yielding the second best prediction on both training and test sets, while 
1-norm SVM without embedding provided the best prediction on the training set but suffered 
from overfitting and decision trees produced the best prediction on the test set. For data set III, 
MILES performed slightly worse than random forests, but better than the other two methods, 
based on the predictions on the test set. Although MILES using Dice distance was not selected, 
since it yielded a large number of selected prototype conformers, it performed equally as good as 
random forests on the test set. For data set IV, MILES significantly outperformed the other 
approaches based on the predictions on the test set. For all the data sets, 1-norm SVM without 
embedding overfit the training set, yielding the best predictions on the training sets and relatively 
low predictions on the test sets. However, after instance-based embedding, MILES performed 
fairly well on both training and test sets without overfitting, and its predictive power was highly 
comparable with other conventional QSAR approaches (Table 7). It was interesting that the 
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classification accuracy and MCC provided the same indications again, even for the comparison 
of different QSAR approaches. 
Table 7. Predictive performance for different models. 
Data 
set 
Methods 
Training set Test set 
Accuracy MCC Accuracy MCC 
I 
MILES
a
 0.941 0.881 0.861 0.725 
Decision tree 0.915 0.830 0.781 0.569 
1-norm SVM 1.000 1.000 0.832 0.668 
Random forest 0.995 0.990 0.891 0.783 
II 
MILES
a
 0.978 0.956 0.904 0.807 
Decision tree 0.955 0.913 0.919 0.837 
1-norm SVM 0.980 0.961 0.882 0.765 
Random forest 0.945 0.896 0.868 0.754 
III 
MILES
b
 0.947 0.885 0.846 0.711 
Decision tree 0.966 0.924 0.838 0.682 
1-norm SVM 0.995 0.988 0.812 0.624 
Random forest 0.982 0.959 0.855 0.717 
IV 
MILES
b
 0.898 0.811 0.794 0.584 
Decision tree 0.914 0.829 0.698 0.398 
1-norm SVM 0.952 0.906 0.714 0.418 
Random forest 0.936 0.877 0.698 0.392 
a
 Manhattan dissimilarity measure; 
b
 Rogers-Tanimoto dissimilarity measure.   
 
Identification of Bioactive Conformers 
After examining the predictive ability of MILES, we tested the ability of MILES in the 
pursuit of the bioactive conformers. Due to the lack of experimental data, the validation can only 
be made for the molecules in data set I. We made use of 12 co-crystallized structures of GSK-3 
with bound small molecules, which adopt bioactive conformers in the complex structures (Table 
8). The direct comparison between the structures of the co-crystallized conformers and the ones 
from conformational sampling is difficult and sometimes impossible, since the conformational 
sampling plus structural minimization may not provide the exact same conformations found in 
the co-crystallized complex, due to the lack of protein environment in the conformational search 
process. So we adopted an indirect validation method. We seeded the 12 co-crystallized 
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conformers in the set of sampled conformers generated through extensive exploration of 
conformational space. Then we calculated their contributions         to the classification of the 
relevant positive molecules as described above (Table 8). 
Table 8. Validations on the prediction of bioactive conformers. 
ID
a
 Name
b
 PDB ID
c
 Contribution
d
 Rank
e
 ni
f
 
23 AR 1Q5K 2.792 3 117 
37 Benzoimidazole-1 2O5K 0 N.A.
g
 138 
50 Jonjon-1 2OW3 2.827 6 38 
59 LM-4 1Q3W 0.858 1 2 
60 LM-5 1UV5 11.941 1 3 
77 LM-29 1Q41 8.576 2 7 
97 Maleimide 1R0E 0 N.A. 
g
 121 
98 OxaD-0 3F7Z 10.629 1 53 
99 OxaD-00 3GB2 4.637 2 9 
153 Pyzo-11 3L1S 10.371 1 11 
198 RM-0 1Q4L 5.568 2 25 
199 Staurosporine 1Q3D 22.359 1 5 
 
a
 Molecule index in the data set; 
b
 molecular name in the data set; 
c
 Protein Data Bank index for 
the protein structure from which the experimental conformer was extracted; 
d
 contribution 
        calculated using equation 6; 
e
 the rank in the set of contributions; 
f
 the number of 
conformers for each molecule; g the rank cannot be determined and the conformer was predicted 
to be irrelevant to classification based on the MILES method. 
 
Three out of 12 molecules are highly flexible, adopting more than 100 conformers. For 
these three, MILES only correctly predicted one co-crystallized conformer as the third most 
significant conformer contributing to the classification of the molecule named AR. It incorrectly 
predicted the other two co-crystallized conformers as irrelevant conformers in terms of the 
contribution to the classification of benzoimidazole-1 and maleimide. 
But for the molecules adopting less than 100 conformers, which had relatively rigid 
structures, MILES correctly predicted all the co-crystallized conformers as significant 
conformers for the classification of positive molecules. Five co-crystallized conformers were 
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predicted to be the most significant conformers, i.e., the bioactive conformers; three co-
crystallized conformers were predicted to be the second most significant conformers; and one co-
crystallized conformer was predicted to be the sixth most significant conformer, based on the 
calculations of        . So the pursuit of bioactive conformers is easy for relatively rigid 
molecules and relatively more difficult for the highly flexible ones.  
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CONCLUSIONS  
We have successfully implemented a multiple-instance learning (MIL) framework, 
multiple-instance learning via embedded instance selection (MILES), for drug activity 
prediction. The molecules and relevant conformers were described using superior 3D descriptors, 
pharmacophore fingerprints, encoded as binary strings. The instance-based embedding was 
accomplished using dissimilarity measures designed for calculations on binary strings. The joint 
feature selection and classification was accomplished using a wrapper model based on 1-norm 
SVM. We have used the approach for the prediction of the labels of molecules interacting with 
four therapeutic targets, including GSK-3, CBrs, and P-gp. Based on the predictive performance, 
our proposed approach was highly competitive with conventional classification approaches based 
on classical QSAR principle. However, the proposed method, unlike conventional classification 
approaches, can also predict the contributions of individual conformers for each molecule and 
further can identify the putative bioactive conformer. These unique characteristics make the 
proposed method very useful for the pursuit of biologically significant conformers. Finally, we 
have validated that the proposed approach is highly useful in the pursuit of bioactive conformers. 
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